Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Lee Hambright is an analyst at Bernstein. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
11/20/2024 | MDT | Buy Now | Medtronic | $86.44 | 12.22% | Lee Hambright69% | $96 → $97 | Maintains | Outperform | Get Alert |
11/06/2024 | PODD | Buy Now | Insulet | $324.75 | -7.62% | Lee Hambright69% | → $300 | Initiates | → Outperform | Get Alert |
11/06/2024 | TNDM | Buy Now | Tandem Diabetes Care | $23.08 | 81.98% | Lee Hambright69% | → $42 | Initiates | → Outperform | Get Alert |
10/25/2024 | DXCM | Buy Now | DexCom | $84.51 | 1.76% | Lee Hambright69% | $82 → $86 | Maintains | Outperform | Get Alert |
10/24/2024 | BSX | Buy Now | Boston Scientific | $105.20 | -4.94% | Lee Hambright69% | $92 → $100 | Maintains | Outperform | Get Alert |
10/17/2024 | ABT | Buy Now | Abbott Laboratories | $134.08 | 2.92% | Lee Hambright69% | $133 → $138 | Maintains | Outperform | Get Alert |
05/31/2023 | ISRG | Buy Now | Intuitive Surgical | $564.00 | -35.28% | Lee Hambright69% | $350 → $365 | Maintains | Outperform | Get Alert |
05/26/2023 | MDT | Buy Now | Medtronic | $86.44 | 14.53% | Lee Hambright69% | $100 → $99 | Maintains | Outperform | Get Alert |
05/03/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $96.75 | 57.11% | Lee Hambright69% | $136 → $152 | Maintains | Market Perform | Get Alert |
04/20/2023 | ISRG | Buy Now | Intuitive Surgical | $564.00 | -37.94% | Lee Hambright69% | $325 → $350 | Maintains | Outperform | Get Alert |
01/26/2023 | ABT | Buy Now | Abbott Laboratories | $134.08 | -1.55% | Lee Hambright69% | $125 → $132 | Maintains | Outperform | Get Alert |
07/15/2022 | DXCM | Buy Now | DexCom | $84.51 | 24.24% | Lee Hambright69% | → $105 | Initiates | → Outperform | Get Alert |
03/16/2022 | JNJ | Buy Now | Johnson & Johnson | $151.00 | 21.19% | Lee Hambright69% | → $183 | Downgrade | Outperform → Market Perform | Get Alert |
03/16/2022 | SYK | Buy Now | Stryker | $394.21 | -25.17% | Lee Hambright69% | $288 → $295 | Upgrade | Market Perform → Outperform | Get Alert |
03/16/2022 | EW | Buy Now | Edwards Lifesciences | $78.00 | 73.08% | Lee Hambright69% | $132 → $135 | Upgrade | Market Perform → Outperform | Get Alert |
10/11/2019 | JNJ | Buy Now | Johnson & Johnson | $151.00 | — | Lee Hambright69% | — | Upgrade | Market Perform → Outperform | Get Alert |
06/27/2018 | SYK | Buy Now | Stryker | $394.21 | -55.1% | Lee Hambright69% | → $177 | Initiates | → Market Perform | Get Alert |
06/27/2018 | JNJ | Buy Now | Johnson & Johnson | $151.00 | -14.57% | Lee Hambright69% | → $129 | Initiates | → Market Perform | Get Alert |
06/27/2018 | EW | Buy Now | Edwards Lifesciences | $78.00 | 111.54% | Lee Hambright69% | → $165 | Initiates | → Market Perform | Get Alert |
12/04/2014 | EW | Buy Now | Edwards Lifesciences | $78.00 | 98.72% | Lee Hambright69% | → $155 | Initiates | → Outperform | Get Alert |
10/01/2014 | JNJ | Buy Now | Johnson & Johnson | $151.00 | — | Lee Hambright69% | — | Downgrade | → Market Perform | Get Alert |
11/25/2013 | SYK | Buy Now | Stryker | $394.21 | -78.69% | Lee Hambright69% | $75 → $84 | Upgrade | Market Perform → Outperform | Get Alert |